“INVESTIGATING THE EFFICACY AND SAFETY OF SGLT2 INHIBITORS FOR CARDIOVASCULAR PROTECTION IN PATIENTS WITH OBESITY AND TYPE 2 DIABETES”. 2025. The Research of Medical Science Review 3 (4): 307-12. http://www.thermsr.com/index.php/Journal/article/view/929.